Medinol obtains CE Mark for Presillion Stent

The Presillion comes in diameters ranging from 2.5-4mm and in lengths ranging from 8-32mm. The Presillion stent system can be used to treat various lesion types: de novo, restenotic lesions, total occlusions, bifurcations, and acute myocardial infarction. Medinol partnered with Cordis, a Johnson and Johnson company, for distribution of Presillion globally.

Kobi Richter, chairman of the board and chief technology officer of Medinol, said: “Cobalt Chromium enables us to reduce the strut thickness and overall cell size by up to 25% compared to stainless steel while retaining superior scaffolding through the unique flexible closed cell design; this material also maintains a much higher fatigue resistance and radiopacity than the common stainless steel stents.”